 Connection
Joana Mack to Treatment Outcome
This is a "connection" page, showing publications Joana Mack has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.274 |
|
|
|
-
Mack JM, Peterson EC, Crary SE, Moran JH, Neville K, Pierce CD, Richter GT. Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations. Pediatr Blood Cancer. 2022 08; 69(8):e29733.
Score: 0.098
-
Mack JM, Richter GT, Crary SE. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphat Res Biol. 2018 06; 16(3):278-281.
Score: 0.074
-
Mack JM, Richter GT, Becton D, Salem O, Hill SEM, Crary SE. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations. Pediatr Blood Cancer. 2018 06; 65(6):e27008.
Score: 0.074
-
Raichlin E, Haglund NA, Dumitru I, Lyden ER, Johnston MD, Mack JM, Windle JR, Lowes BD. Worsening renal function in patients with acute decompensated heart failure treated with ultrafiltration: predictors and outcomes. J Card Fail. 2014 May; 20(5):376.e25-32.
Score: 0.014
-
Raichlin E, Haglund NA, Dumitru I, Lyden ER, Johnston MD, Mack JM, Windle JR, Lowes BD. Worsening renal function in patients with acute decompensated heart failure treated with ultrafiltration: predictors and outcomes. J Card Fail. 2013 Dec; 19(12):787-94.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|